Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
67 Cards in this Set
- Front
- Back
Observational study that collects data from a group of people to assess a frequency of disease, at a particular point of time |
Cross-sectional study |
|
Can show disease prevalence, risk factor association with disease but noes not establish causality |
Cross-sectional study |
|
Observational and retrospective study that compares group of people with disease to a group without disease |
Case-control study |
|
Looks for prior exposure or risk factor, use Odds ratio (OR) |
Case-control study |
|
Compares a group with a given exposure or risk factor to a group without such exposure |
Cohort study |
|
Study that can be observational and prospective or retrospective |
Cohort study |
|
Looks to see if exposure or risk factor increase the likelihood of disease, use relative risk (RR) |
Cohort study |
|
Compares the frequency with which both monozygotic twins or both dizygotic twins develop same disease |
Twin concordance study |
|
Measure heritability and influence of environmental factors (nature vs nurture) |
Twin concordance study |
|
Compares siblings raised by biological vs adoptive parents |
Adoption study |
|
Experimental study involving humans, compares therapeutic benefits of 2 or more treatment, or of treatment and placebo |
Clinical trial |
|
Clinical trial study improves quality when study is |
Randomized Controlled Double blinded |
|
Drugs trial Phase I |
Small number of healthy volunteers Purpose (is it safe) |
|
Drugs trial Phase II |
Small number of patients with disease of interest Purpose (does it work) |
|
Drugs trial Phase III |
Large number of patients randomly assigned either to the treatment under investigation or the best available treatment Purpose (is it as good or better) |
|
Drugs trial Phase IV |
Postmarketing surveillance trial of patients after approval Purpose (can it stay) |
|
Neither patient nor doctor knows whether the patient is in the treatment or control group |
Double-blinded |
|
Random assignment to experimental group and control group |
Randomized |
|
Experimental group receives experimental treatment and control group receives placebo |
Controlled |
|
Proportion of all people with disease who test positive, or the probability that a test detects disease when disease is present |
Sensitivity (true positive rate) |
|
Proportion of all people without disease who test negative, or the probability that a test indicates non-disease when disease is absent |
Specificity (true negative rate) |
|
Proportion of positive test results that are true positive |
Positive predictive value |
|
Proportion of negative test results that are true negative |
Negative predictive value |
|
What is the formula of sensitivity |
=TP/ (TP+FN) |
|
If sensitivity is 100% TP/ (TP+FH) = |
1 FN=0, and all negatives must be TNs |
|
What is the formula of Specificity |
TN/ (TN+FP) |
|
If specificity is 100% TN/ (TN+FP)= |
1 FP=0, and all positives must be TPs |
|
What is the formula of Positive predictive value |
TP/(TP+FP) |
|
Positive predictive value varies directly with |
Prevalence and Pretest probability |
|
What is the formula of negative predictive value |
TN/(TN+FN) |
|
Negative predictive value varies inversely with |
Prevalence or pretest probability |
|
Test + and Disease + |
True positive |
|
Test + Disease - |
False positive |
|
Test - Disease + |
False negative
|
|
Test - Disease - |
True positive |
|
How is incidence rate defined? |
Number of new casa in a specified time period / Population at risk during the same time period |
|
How is prevalence defined? |
Number of existing cases / Population at risk |
|
What is odds ratio? |
Odds that the group with disease was exposed to a risk factor (cases) divided by the odds that the group without disease was exposed. (controls) |
|
How is odds ratio calculated? |
a/c / b/d = ad/bc |
|
What is relative risk? |
Risk of developing disease in the exposed group divided by risk in the unexposed group |
|
Quantifying risk typically used in case-control studies |
Odds ratio |
|
Quantifying risk typically used in cohort studies |
Relative risk |
|
What is the relative risk reduction? |
The proportion of risk reduction attributable to the intervention as compared to the control |
|
How is relative risk reduction calculated? |
RRR = 1-RR |
|
What is attributable risk? |
The difference in risk between exposed and unexposed groups, or the proportion of disease occurrences that are attributable to the exposure |
|
How is relative risk calculated? |
RR = a/(a + b) / c/(c + d) |
|
How is attributable risk calculated? |
AR = a/a+b - c/c+d |
|
What is absolute risk reduction(ARR)? |
The difference in risk attributable to the intervention as compared to a control |
|
What is the number needed to treat? |
Number of patients who need to be treated for 1 patient to benefit. Calculated as 1/ARR |
|
What is the number needed to harm? |
Number of patients who need to be exposed to a risk factor for 1 patient to be harmed. Calculated as 1/AR |
|
What is the mean? |
Sum of values/total number of values |
|
What is the median? |
middle value of a list of data sorted from least to greatest |
|
What is the mode? |
most common value |
|
What is the standard deviation? |
How much variability exists from the mean in a set of values |
|
What is the standard error of the mean? |
An estimation of how much variability exists between the sample mean and the true population mean |
|
How is the standard error of the mean calculated? |
SEM = SD/√n |
|
How is the graph shaped in normal distribution? |
Bell-shaped Mean = medium = mode |
|
What is bimodal distribution? |
Nonnormal, suggests 2 different populations |
|
What is positive skew distribution? |
Nonnormal, Asymmetry with longer tail on the right. Mean>median>mode |
|
What is negative skew? |
Nonnormal, asymmetry with longer tail on the left Mean<median<mode |
|
Stating that there is an effect when one exists |
Correct result |
|
Stating that there is an effect when none exists (null hypothesis incorrectly rejected in favor of alternative hypothesis) |
Type I error |
|
Stating that there is not an effect when one exists (null hypothesis is not rejected when it is in fact false) |
Type II error
|
|
How do you increase power and decrease the probability of making a type II error? |
Increasing sample size, increased expected effect size and increasing precision of measurement |
|
What is confidence interval (CI)? |
Range of values in which a specified probability of the means of repeated samples would be expected to fall |
|
When CI = 95%, Z = ... |
1.96 = 2 |
|
When CI = 99%, Z =... |
2.58 |